1
|
Dos Reis MA, Künas CA, da Silva Araújo T, Schneiders J, de Azevedo PB, Nakayama LF, Rados DRV, Umpierre RN, Berwanger O, Lavinsky D, Malerbi FK, Navaux POA, Schaan BD. Advancing healthcare with artificial intelligence: diagnostic accuracy of machine learning algorithm in diagnosis of diabetic retinopathy in the Brazilian population. Diabetol Metab Syndr 2024; 16:209. [PMID: 39210394 PMCID: PMC11360296 DOI: 10.1186/s13098-024-01447-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/20/2024] [Accepted: 08/12/2024] [Indexed: 09/04/2024] Open
Abstract
BACKGROUND In healthcare systems in general, access to diabetic retinopathy (DR) screening is limited. Artificial intelligence has the potential to increase care delivery. Therefore, we trained and evaluated the diagnostic accuracy of a machine learning algorithm for automated detection of DR. METHODS We included color fundus photographs from individuals from 4 databases (primary and specialized care settings), excluding uninterpretable images. The datasets consist of images from Brazilian patients, which differs from previous work. This modification allows for a more tailored application of the model to Brazilian patients, ensuring that the nuances and characteristics of this specific population are adequately captured. The sample was fractionated in training (70%) and testing (30%) samples. A convolutional neural network was trained for image classification. The reference test was the combined decision from three ophthalmologists. The sensitivity, specificity, and area under the ROC curve of the algorithm for detecting referable DR (moderate non-proliferative DR; severe non-proliferative DR; proliferative DR and/or clinically significant macular edema) were estimated. RESULTS A total of 15,816 images (4590 patients) were included. The overall prevalence of any degree of DR was 26.5%. Compared with human evaluators (manual method of diagnosing DR performed by an ophthalmologist), the deep learning algorithm achieved an area under the ROC curve of 0.98 (95% CI 0.97-0.98), with a specificity of 94.6% (95% CI 93.8-95.3) and a sensitivity of 93.5% (95% CI 92.2-94.9) at the point of greatest efficiency to detect referable DR. CONCLUSIONS A large database showed that this deep learning algorithm was accurate in detecting referable DR. This finding aids to universal healthcare systems like Brazil, optimizing screening processes and can serve as a tool for improving DR screening, making it more agile and expanding care access.
Collapse
Affiliation(s)
- Mateus A Dos Reis
- Graduate Program in Medical Sciences: Endocrinology, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
- Universidade Feevale, Novo Hamburgo, RS, Brazil.
| | - Cristiano A Künas
- Institute of Informatics, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - Thiago da Silva Araújo
- Institute of Informatics, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - Josiane Schneiders
- Graduate Program in Medical Sciences: Endocrinology, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | | | - Luis F Nakayama
- Department of Ophthalmology and Visual Sciences, Universidade Federal de São Paulo, São Paulo, Brazil
- Laboratory for Computational Physiology, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - Dimitris R V Rados
- Graduate Program in Medical Sciences: Endocrinology, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
- TelessaúdeRS Project, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - Roberto N Umpierre
- TelessaúdeRS Project, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
- Department of Social Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
| | - Otávio Berwanger
- The George Institute for Global Health, Imperial College London, London, UK
| | - Daniel Lavinsky
- Graduate Program in Medical Sciences: Endocrinology, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
- Department of Ophthalmology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
| | - Fernando K Malerbi
- Department of Ophthalmology and Visual Sciences, Universidade Federal de São Paulo, São Paulo, Brazil
| | - Philippe O A Navaux
- Institute of Informatics, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
| | - Beatriz D Schaan
- Graduate Program in Medical Sciences: Endocrinology, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
- Institute for Health Technology Assessment (IATS) - CNPq, Porto Alegre, Brazil
- Endocrinology Unit, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil
| |
Collapse
|
2
|
Riotto E, Gasser S, Potic J, Sherif M, Stappler T, Schlingemann R, Wolfensberger T, Konstantinidis L. Accuracy of Autonomous Artificial Intelligence-Based Diabetic Retinopathy Screening in Real-Life Clinical Practice. J Clin Med 2024; 13:4776. [PMID: 39200918 PMCID: PMC11355215 DOI: 10.3390/jcm13164776] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2024] [Revised: 07/24/2024] [Accepted: 08/08/2024] [Indexed: 09/02/2024] Open
Abstract
Background: In diabetic retinopathy, early detection and intervention are crucial in preventing vision loss and improving patient outcomes. In the era of artificial intelligence (AI) and machine learning, new promising diagnostic tools have emerged. The IDX-DR machine (Digital Diagnostics, Coralville, IA, USA) represents a diagnostic tool that combines advanced imaging techniques, AI algorithms, and deep learning methodologies to identify and classify diabetic retinopathy. Methods: All patients that participated in our AI-based DR screening were considered for this study. For this study, all retinal images were additionally reviewed retrospectively by two experienced retinal specialists. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were calculated for the IDX-DR machine compared to the graders' responses. Results: We included a total of 2282 images from 1141 patients who were screened between January 2021 and January 2023 at the Jules Gonin Eye Hospital in Lausanne, Switzerland. Sensitivity was calculated to be 100% for 'no DR', 'mild DR', and 'moderate DR'. Specificity for no DR', 'mild DR', 'moderate DR', and 'severe DR' was calculated to be, respectively, 78.4%, 81.2%, 93.4%, and 97.6%. PPV was calculated to be, respectively, 36.7%, 24.6%, 1.4%, and 0%. NPV was calculated to be 100% for each category. Accuracy was calculated to be higher than 80% for 'no DR', 'mild DR', and 'moderate DR'. Conclusions: In this study, based in Jules Gonin Eye Hospital in Lausanne, we compared the autonomous diagnostic AI system of the IDX-DR machine detecting diabetic retinopathy to human gradings established by two experienced retinal specialists. Our results showed that the ID-x DR machine constantly overestimates the DR stages, thus permitting the clinicians to fully trust negative results delivered by the screening software. Nevertheless, all fundus images classified as 'mild DR' or greater should always be controlled by a specialist in order to assert whether the predicted stage is truly present.
Collapse
|
3
|
Huang JJ, Channa R, Wolf RM, Dong Y, Liang M, Wang J, Abramoff MD, Liu TYA. Autonomous artificial intelligence for diabetic eye disease increases access and health equity in underserved populations. NPJ Digit Med 2024; 7:196. [PMID: 39039218 PMCID: PMC11263546 DOI: 10.1038/s41746-024-01197-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2024] [Accepted: 07/12/2024] [Indexed: 07/24/2024] Open
Abstract
Diabetic eye disease (DED) is a leading cause of blindness in the world. Annual DED testing is recommended for adults with diabetes, but adherence to this guideline has historically been low. In 2020, Johns Hopkins Medicine (JHM) began deploying autonomous AI for DED testing. In this study, we aimed to determine whether autonomous AI implementation was associated with increased adherence to annual DED testing, and how this differed across patient populations. JHM primary care sites were categorized as "non-AI" (no autonomous AI deployment) or "AI-switched" (autonomous AI deployment by 2021). We conducted a propensity score weighting analysis to compare change in adherence rates from 2019 to 2021 between non-AI and AI-switched sites. Our study included all adult patients with diabetes (>17,000) managed within JHM and has three major findings. First, AI-switched sites experienced a 7.6 percentage point greater increase in DED testing than non-AI sites from 2019 to 2021 (p < 0.001). Second, the adherence rate for Black/African Americans increased by 12.2 percentage points within AI-switched sites but decreased by 0.6% points within non-AI sites (p < 0.001), suggesting that autonomous AI deployment improved access to retinal evaluation for historically disadvantaged populations. Third, autonomous AI is associated with improved health equity, e.g. the adherence rate gap between Asian Americans and Black/African Americans shrank from 15.6% in 2019 to 3.5% in 2021. In summary, our results from real-world deployment in a large integrated healthcare system suggest that autonomous AI is associated with improvement in overall DED testing adherence, patient access, and health equity.
Collapse
Affiliation(s)
- Jane J Huang
- Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Roomasa Channa
- University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA
| | - Risa M Wolf
- Johns Hopkins Pediatric Diabetes Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Yiwen Dong
- Department of Biostatistics, Johns Hopkins University, Baltimore, MD, USA
| | - Mavis Liang
- Department of Biostatistics, Johns Hopkins University, Baltimore, MD, USA
| | - Jiangxia Wang
- Department of Biostatistics, Johns Hopkins University, Baltimore, MD, USA
| | - Michael D Abramoff
- Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, USA
- Department of Electrical and Computer Engineering, University of Iowa, Iowa City, IA, USA
| | - T Y Alvin Liu
- Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
| |
Collapse
|
4
|
Horie S, Suzuki Y, Yoshida T, Ohno-Matsui K. Blue Wavelength of Scanning Laser Ophthalmoscope Potentially Detects Arteriosclerotic Lesions in Diabetic Retinopathy. Diagnostics (Basel) 2024; 14:1411. [PMID: 39001301 PMCID: PMC11241710 DOI: 10.3390/diagnostics14131411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2024] [Revised: 06/26/2024] [Accepted: 06/28/2024] [Indexed: 07/16/2024] Open
Abstract
(1) Background: The fundus examination is one of the best and popular methods in the assessment of vascular status in the human body. Direct viewing of retinal vessels by ophthalmoscopy has been utilized in judging hypertensive change or arteriosclerosis. Recently, fundus imaging with the non-mydriatic scanning laser ophthalmoscope (SLO) has been widely used in ophthalmological clinics since it has multimodal functions for optical coherence tomography or angiography with contrast agent dye. The purpose of this study was to examine the utility in detecting arteriosclerosis of retinal vessels in SLO images; (2) Methods: Both color and blue standard field SLO images of eyes with diabetic retinopathy (DR) were examined retrospectively. Retinal arteriosclerosis in color SLO images was graded according to the Scheie classification. Additionally, characteristics of retinal arterioles in blue SLO images were identified and examined for their relevance to arteriosclerosis grades, stages of DR or general complications; (3) Results: Relative to color fundus images, blue SLO images showed distinct hyper-reflective retinal arterioles against a monotone background. Irregularities of retinal arterioles identified in blue SLO images were frequently observed in the eyes of patients with severe arteriosclerosis (Grade 3: 79.0% and Grade 4: 81.8%). Furthermore, the findings on arterioles were more frequently associated with the eyes of DR patients with renal dysfunction (p < 0.05); (4) Conclusions: While color SLO images are equally as useful in assessing retinal arteriosclerosis as photography or ophthalmoscopy, the corresponding blue SLO images show arteriosclerotic lesions with high contrast in a monotone background. Retinal arteriosclerosis in eyes of advanced grades or advanced DR frequently show irregularities of retinal arterioles in the blue images. The findings of low, uneven, or discontinuous attenuation were easier to find in blue than in color SLO images. Consequently, blue SLO images can show pathological micro-sclerosis in retinal arterioles and are potentially one of the safe and practical methods for the vascular assessment of diabetic patients.
Collapse
Affiliation(s)
- Shintaro Horie
- Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo 113-8510, Japan
| | - Yudai Suzuki
- Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo 113-8510, Japan
- Department of Ophthalmology, Tokyo Metropolitan Tama Medical Center, Tokyo 113-8510, Japan
| | - Takeshi Yoshida
- Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo 113-8510, Japan
- Department of Advanced Ophthalmic Imaging, Tokyo Medical and Dental University, Tokyo 113-8519, Japan
| | - Kyoko Ohno-Matsui
- Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo 113-8510, Japan
| |
Collapse
|
5
|
Joseph S, Selvaraj J, Mani I, Kumaragurupari T, Shang X, Mudgil P, Ravilla T, He M. Diagnostic Accuracy of Artificial Intelligence-Based Automated Diabetic Retinopathy Screening in Real-World Settings: A Systematic Review and Meta-Analysis. Am J Ophthalmol 2024; 263:214-230. [PMID: 38438095 DOI: 10.1016/j.ajo.2024.02.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2023] [Revised: 02/03/2024] [Accepted: 02/12/2024] [Indexed: 03/06/2024]
Abstract
PURPOSE To evaluate the diagnostic accuracy of artificial intelligence (AI)-based automated diabetic retinopathy (DR) screening in real-world settings. DESIGN Systematic review and meta-analysis METHODS: We conducted a systematic review of relevant literature from January 2012 to August 2022 using databases including PubMed, Scopus and Web of Science. The quality of studies was evaluated using Quality Assessment for Diagnostic Accuracy Studies 2 (QUADAS-2) checklist. We calculated pooled accuracy, sensitivity, specificity, and diagnostic odds ratio (DOR) as summary measures. The study protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO - CRD42022367034). RESULTS We included 34 studies which utilized AI algorithms for diagnosing DR based on real-world fundus images. Quality assessment of these studies indicated a low risk of bias and low applicability concern. Among gradable images, the overall pooled accuracy, sensitivity, specificity, and DOR were 81%, 94% (95% CI: 92.0-96.0), 89% (95% CI: 85.0-92.0) and 128 (95% CI: 80-204) respectively. Sub-group analysis showed that, when acceptable quality imaging could be obtained, non-mydriatic fundus images had a better DOR of 143 (95% CI: 82-251) and studies using 2 field images had a better DOR of 161 (95% CI 74-347). Our meta-regression analysis revealed a statistically significant association between DOR and variables such as the income status, and the type of fundus camera. CONCLUSION Our findings indicate that AI algorithms have acceptable performance in screening for DR using fundus images compared to human graders. Implementing a fundus camera with AI-based software has the potential to assist ophthalmologists in reducing their workload and improving the accuracy of DR diagnosis.
Collapse
Affiliation(s)
- Sanil Joseph
- From the Centre for Eye Research Australia (S.J, X.S, M.H), Royal Victorian Eye and Ear Hospital, East Melbourne, Australia; Department of Surgery (Ophthalmology) (S.J, X.S, M.H), The University of Melbourne, Melbourne, Australia; Lions Aravind Institute of Community Ophthalmology (S.J, J.S, T.R), Aravind Eye Care System. Madurai, India.
| | - Jerrome Selvaraj
- Lions Aravind Institute of Community Ophthalmology (S.J, J.S, T.R), Aravind Eye Care System. Madurai, India
| | - Iswarya Mani
- Aravind Eye Hospital and Postgraduate Institute of Ophthalmology (I.M, T.K), Madurai, India
| | | | - Xianwen Shang
- From the Centre for Eye Research Australia (S.J, X.S, M.H), Royal Victorian Eye and Ear Hospital, East Melbourne, Australia; Department of Surgery (Ophthalmology) (S.J, X.S, M.H), The University of Melbourne, Melbourne, Australia
| | - Poonam Mudgil
- School of Medicine (P.M), Western Sydney University, Campbell town, Australia; School of Rural Medicine (P.M), Charles Sturt University, Orange, NSW, Australia
| | - Thulasiraj Ravilla
- Lions Aravind Institute of Community Ophthalmology (S.J, J.S, T.R), Aravind Eye Care System. Madurai, India
| | - Mingguang He
- From the Centre for Eye Research Australia (S.J, X.S, M.H), Royal Victorian Eye and Ear Hospital, East Melbourne, Australia; Department of Surgery (Ophthalmology) (S.J, X.S, M.H), The University of Melbourne, Melbourne, Australia
| |
Collapse
|
6
|
Lim JI, Rachitskaya AV, Hallak JA, Gholami S, Alam MN. Artificial intelligence for retinal diseases. Asia Pac J Ophthalmol (Phila) 2024; 13:100096. [PMID: 39209215 DOI: 10.1016/j.apjo.2024.100096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2024] [Revised: 08/02/2024] [Accepted: 08/20/2024] [Indexed: 09/04/2024] Open
Abstract
PURPOSE To discuss the worldwide applications and potential impact of artificial intelligence (AI) for the diagnosis, management and analysis of treatment outcomes of common retinal diseases. METHODS We performed an online literature review, using PubMed Central (PMC), of AI applications to evaluate and manage retinal diseases. Search terms included AI for screening, diagnosis, monitoring, management, and treatment outcomes for age-related macular degeneration (AMD), diabetic retinopathy (DR), retinal surgery, retinal vascular disease, retinopathy of prematurity (ROP) and sickle cell retinopathy (SCR). Additional search terms included AI and color fundus photographs, optical coherence tomography (OCT), and OCT angiography (OCTA). We included original research articles and review articles. RESULTS Research studies have investigated and shown the utility of AI for screening for diseases such as DR, AMD, ROP, and SCR. Research studies using validated and labeled datasets confirmed AI algorithms could predict disease progression and response to treatment. Studies showed AI facilitated rapid and quantitative interpretation of retinal biomarkers seen on OCT and OCTA imaging. Research articles suggest AI may be useful for planning and performing robotic surgery. Studies suggest AI holds the potential to help lessen the impact of socioeconomic disparities on the outcomes of retinal diseases. CONCLUSIONS AI applications for retinal diseases can assist the clinician, not only by disease screening and monitoring for disease recurrence but also in quantitative analysis of treatment outcomes and prediction of treatment response. The public health impact on the prevention of blindness from DR, AMD, and other retinal vascular diseases remains to be determined.
Collapse
Affiliation(s)
- Jennifer I Lim
- University of Illinois at Chicago, College of Medicine, Department of Ophthalmology and Visual Sciences, Chicago, IL, United States.
| | - Aleksandra V Rachitskaya
- Department of Ophthalmology at Case Western Reserve University, Cleveland Clinic Lerner College of Medicine, Cleveland Clinic Cole Eye Institute, United States
| | - Joelle A Hallak
- University of Illinois at Chicago, College of Medicine, Department of Ophthalmology and Visual Sciences, Chicago, IL, United States; Department of Ophthalmology and Visual Sciences, College of Medicine, University of Illinois at Chicago, Chicago, IL, United States
| | - Sina Gholami
- University of North Carolina at Charlotte, United States
| | - Minhaj N Alam
- University of North Carolina at Charlotte, United States
| |
Collapse
|
7
|
Liu TYA, Huang J, Channa R, Wolf R, Dong Y, Liang M, Wang J, Abramoff M. Autonomous Artificial Intelligence Increases Access and Health Equity in Underserved Populations with Diabetes. RESEARCH SQUARE 2024:rs.3.rs-3979992. [PMID: 38559222 PMCID: PMC10980149 DOI: 10.21203/rs.3.rs-3979992/v1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/04/2024]
Abstract
Diabetic eye disease (DED) is a leading cause of blindness in the world. Early detection and treatment of DED have been shown to be both sight-saving and cost-effective. As such, annual testing for DED is recommended for adults with diabetes and is a Healthcare Effectiveness Data and Information Set (HEDIS) measure. However, adherence to this guideline has historically been low, and access to this sight-saving intervention has particularly been limited for specific populations, such as Black or African American patients. In 2018, the US Food and Drug Agency (FDA) De Novo cleared autonomous artificial intelligence (AI) for diagnosing DED in a primary care setting. In 2020, Johns Hopkins Medicine (JHM), an integrated healthcare system with over 30 primary care sites, began deploying autonomous AI for DED testing in some of its primary care clinics. In this retrospective study, we aimed to determine whether autonomous AI implementation was associated with increased adherence to annual DED testing, and whether this was different for specific populations. JHM primary care sites were categorized as "non-AI" sites (sites with no autonomous AI deployment over the study period and where patients are referred to eyecare for DED testing) or "AI-switched" sites (sites that did not have autonomous AI testing in 2019 but did by 2021). We conducted a difference-in-difference analysis using a logistic regression model to compare change in adherence rates from 2019 to 2021 between non-AI and AI-switched sites. Our study included all adult patients with diabetes managed within our health system (17,674 patients for the 2019 cohort and 17,590 patients for the 2021 cohort) and has three major findings. First, after controlling for a wide range of potential confounders, our regression analysis demonstrated that the odds ratio of adherence at AI-switched sites was 36% higher than that of non-AI sites, suggesting that there was a higher increase in DED testing between 2019 and 2021 at AI-switched sites than at non-AI sites. Second, our data suggested autonomous AI improved access for historically disadvantaged populations. The adherence rate for Black/African Americans increased by 11.9% within AI-switched sites whereas it decreased by 1.2% within non-AI sites over the same time frame. Third, the data suggest that autonomous AI improved health equity by closing care gaps. For example, in 2019, a large adherence rate gap existed between Asian Americans and Black/African Americans (61.1% vs. 45.5%). This 15.6% gap shrank to 3.5% by 2021. In summary, our real-world deployment results in a large integrated healthcare system suggest that autonomous AI improves adherence to a HEDIS measure, patient access, and health equity for patients with diabetes - particularly in historically disadvantaged patient groups. While our findings are encouraging, they will need to be replicated and validated in a prospective manner across more diverse settings.
Collapse
Affiliation(s)
| | | | | | - Risa Wolf
- Johns Hopkins University School of Medicine
| | | | | | | | | |
Collapse
|
8
|
Shou BL, Venkatesh K, Chen C, Ghidey R, Lee JH, Wang J, Channa R, Wolf RM, Abramoff MD, Liu TYA. Risk Factors for Nondiagnostic Imaging in a Real-World Deployment of Artificial Intelligence Diabetic Retinal Examinations in an Integrated Healthcare System: Maximizing Workflow Efficiency Through Predictive Dilation. J Diabetes Sci Technol 2024; 18:302-308. [PMID: 37798955 PMCID: PMC10973867 DOI: 10.1177/19322968231201654] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/07/2023]
Abstract
OBJECTIVE In the pivotal clinical trial that led to Food and Drug Administration De Novo "approval" of the first fully autonomous artificial intelligence (AI) diabetic retinal disease diagnostic system, a reflexive dilation protocol was used. Using real-world deployment data before implementation of reflexive dilation, we identified factors associated with nondiagnostic results. These factors allow a novel predictive dilation workflow, where patients most likely to benefit from pharmacologic dilation are dilated a priori to maximize efficiency and patient satisfaction. METHODS Retrospective review of patients who were assessed with autonomous AI at Johns Hopkins Medicine (8/2020 to 5/2021). We constructed a multivariable logistic regression model for nondiagnostic results to compare characteristics of patients with and without diagnostic results, using adjusted odds ratio (aOR). P < .05 was considered statistically significant. RESULTS Of 241 patients (59% female; median age = 59), 123 (51%) had nondiagnostic results. In multivariable analysis, type 1 diabetes (T1D, aOR = 5.82, 95% confidence interval [CI]: 1.45-23.40, P = .01), smoking (aOR = 2.86, 95% CI: 1.36-5.99, P = .005), and age (every 10-year increase, aOR = 2.12, 95% CI: 1.62-2.77, P < .001) were associated with nondiagnostic results. Following feature elimination, a predictive model was created using T1D, smoking, age, race, sex, and hypertension as inputs. The model showed an area under the receiver-operator characteristics curve of 0.76 in five-fold cross-validation. CONCLUSIONS We used factors associated with nondiagnostic results to design a novel, predictive dilation workflow, where patients most likely to benefit from pharmacologic dilation are dilated a priori. This new workflow has the potential to be more efficient than reflexive dilation, thus maximizing the number of at-risk patients receiving their diabetic retinal examinations.
Collapse
Affiliation(s)
- Benjamin L. Shou
- School of Medicine, The Johns Hopkins
University, Baltimore, MD, USA
| | - Kesavan Venkatesh
- Whiting School of Engineering, The
Johns Hopkins University, Baltimore, MD, USA
| | - Chang Chen
- Bloomberg School of Public Health, The
Johns Hopkins University, Baltimore, MD, USA
| | - Ronel Ghidey
- Bloomberg School of Public Health, The
Johns Hopkins University, Baltimore, MD, USA
| | - Jae Hyoung Lee
- Bloomberg School of Public Health, The
Johns Hopkins University, Baltimore, MD, USA
| | - Jiangxia Wang
- Bloomberg School of Public Health, The
Johns Hopkins University, Baltimore, MD, USA
| | - Roomasa Channa
- Department of Ophthalmology and Visual
Sciences, University of Wisconsin-Madison, Madison, WI, USA
| | - Risa M. Wolf
- Department of Pediatrics, Division of
Pediatric Endocrinology, The Johns Hopkins University, Baltimore, MD, USA
| | - Michael D. Abramoff
- Department of Ophthalmology and Visual
Sciences, The University of Iowa, Iowa City, IA, USA
| | - T. Y. Alvin Liu
- Wilmer Eye Institute, The Johns Hopkins
University, Baltimore, MD, USA
| |
Collapse
|
9
|
Martínez-García I, Cavero-Redondo I, Álvarez-Bueno C, Pascual-Morena C, Gómez-Guijarro MD, Saz-Lara A. Non-invasive skin autofluorescence as a screening method for diabetic retinopathy. Diabetes Metab Res Rev 2024; 40:e3721. [PMID: 37672325 DOI: 10.1002/dmrr.3721] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/13/2022] [Revised: 04/21/2023] [Accepted: 07/24/2023] [Indexed: 09/07/2023]
Abstract
Diabetic retinopathy (DR) is a public health problem and a common cause of blindness. It is diagnosed by fundus examination; however, this is a costly and time-consuming method. Non-invasive skin autofluorescence (SAF) may be an accessible, fast and simple alternative for screening and early diagnosis of DR. The aim of this study was to evaluate the accuracy of SAF as a screening method for DR. A systematic search of MEDLINE, Scopus, and Web of Science databases was performed. Random effects models for sensitivity, specificity, positive likelihood ratio (PLR) and negative likelihood ratio (NLR), diagnostic odds ratio (dOR) value and 95% CIs were used to calculate test accuracy. In addition, hierarchical summary receiver operating characteristic curves (HSROC) were used to summarise the overall test performance. Four studies were included in the meta-analysis. Pooled sensitivity and specificity were 0.79 (95% CI 0.72-0.88; I2 = 0.0%) and 0.54 (95% CI 0.32-0.92; I2 = 97.0%), respectively. The dOR value for the diagnosis of DR using SAF was 5.11 (95% CI 1.81-14.48: I2 = 85.9%). The PRL was 2.17 (95% CI 0.62-7.64) and the NRL was 0.27 (95% CI 0.07-1.03). Heterogeneity was not relevant in sensitivity and considerable in specificity. The 95% confidence region of the HSROC included all studies. SAF as a screening test for DR shows sufficient accuracy for its use in clinical settings. SAF may be an appropriate method for DR screening, and further research is needed to recommend it as a diagnostic method.
Collapse
Affiliation(s)
| | - Iván Cavero-Redondo
- Health and Social Research Center, Universidad de Castilla-La Mancha, Cuenca, Spain
- Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Talca, Chile
| | - Celia Álvarez-Bueno
- Health and Social Research Center, Universidad de Castilla-La Mancha, Cuenca, Spain
- Universidad Politécnica y Artística del Paraguay, Asunción, Paraguay
| | | | | | - Alicia Saz-Lara
- Health and Social Research Center, Universidad de Castilla-La Mancha, Cuenca, Spain
| |
Collapse
|
10
|
Song A, Borkar DS. Advances in Teleophthalmology Screening for Diabetic Retinopathy. Int Ophthalmol Clin 2024; 64:97-113. [PMID: 38146884 DOI: 10.1097/iio.0000000000000505] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2023]
|
11
|
Dow ER, Khan NC, Chen KM, Mishra K, Perera C, Narala R, Basina M, Dang J, Kim M, Levine M, Phadke A, Tan M, Weng K, Do DV, Moshfeghi DM, Mahajan VB, Mruthyunjaya P, Leng T, Myung D. AI-Human Hybrid Workflow Enhances Teleophthalmology for the Detection of Diabetic Retinopathy. OPHTHALMOLOGY SCIENCE 2023; 3:100330. [PMID: 37449051 PMCID: PMC10336195 DOI: 10.1016/j.xops.2023.100330] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/31/2022] [Revised: 05/04/2023] [Accepted: 05/08/2023] [Indexed: 07/18/2023]
Abstract
Objective Detection of diabetic retinopathy (DR) outside of specialized eye care settings is an important means of access to vision-preserving health maintenance. Remote interpretation of fundus photographs acquired in a primary care or other nonophthalmic setting in a store-and-forward manner is a predominant paradigm of teleophthalmology screening programs. Artificial intelligence (AI)-based image interpretation offers an alternative means of DR detection. IDx-DR (Digital Diagnostics Inc) is a Food and Drug Administration-authorized autonomous testing device for DR. We evaluated the diagnostic performance of IDx-DR compared with human-based teleophthalmology over 2 and a half years. Additionally, we evaluated an AI-human hybrid workflow that combines AI-system evaluation with human expert-based assessment for referable cases. Design Prospective cohort study and retrospective analysis. Participants Diabetic patients ≥ 18 years old without a prior DR diagnosis or DR examination in the past year presenting for routine DR screening in a primary care clinic. Methods Macula-centered and optic nerve-centered fundus photographs were evaluated by an AI algorithm followed by consensus-based overreading by retina specialists at the Stanford Ophthalmic Reading Center. Detection of more-than-mild diabetic retinopathy (MTMDR) was compared with in-person examination by a retina specialist. Main Outcome Measures Sensitivity, specificity, accuracy, positive predictive value, and gradability achieved by the AI algorithm and retina specialists. Results The AI algorithm had higher sensitivity (95.5% sensitivity; 95% confidence interval [CI], 86.7%-100%) but lower specificity (60.3% specificity; 95% CI, 47.7%-72.9%) for detection of MTMDR compared with remote image interpretation by retina specialists (69.5% sensitivity; 95% CI, 50.7%-88.3%; 96.9% specificity; 95% CI, 93.5%-100%). Gradability of encounters was also lower for the AI algorithm (62.5%) compared with retina specialists (93.1%). A 2-step AI-human hybrid workflow in which the AI algorithm initially rendered an assessment followed by overread by a retina specialist of MTMDR-positive encounters resulted in a sensitivity of 95.5% (95% CI, 86.7%-100%) and a specificity of 98.2% (95% CI, 94.6%-100%). Similarly, a 2-step overread by retina specialists of AI-ungradable encounters improved gradability from 63.5% to 95.6% of encounters. Conclusions Implementation of an AI-human hybrid teleophthalmology workflow may both decrease reliance on human specialist effort and improve diagnostic accuracy. Financial Disclosures Proprietary or commercial disclosure may be found after the references.
Collapse
Affiliation(s)
- Eliot R. Dow
- Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California
- Veterans Affairs Palo Alto Health Care System, Palo Alto, California
| | - Nergis C. Khan
- Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California
| | - Karen M. Chen
- Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California
| | - Kapil Mishra
- Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California
| | - Chandrashan Perera
- Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California
| | - Ramsudha Narala
- Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California
| | - Marina Basina
- Stanford Healthcare, Stanford University, Palo Alto, California
| | - Jimmy Dang
- Stanford Healthcare, Stanford University, Palo Alto, California
| | - Michael Kim
- Stanford Healthcare, Stanford University, Palo Alto, California
| | - Marcie Levine
- Stanford Healthcare, Stanford University, Palo Alto, California
| | - Anuradha Phadke
- Stanford Healthcare, Stanford University, Palo Alto, California
| | - Marilyn Tan
- Stanford Healthcare, Stanford University, Palo Alto, California
| | - Kirsti Weng
- Stanford Healthcare, Stanford University, Palo Alto, California
| | - Diana V. Do
- Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California
| | - Darius M. Moshfeghi
- Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California
| | - Vinit B. Mahajan
- Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California
- Veterans Affairs Palo Alto Health Care System, Palo Alto, California
| | - Prithvi Mruthyunjaya
- Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California
| | - Theodore Leng
- Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California
| | - David Myung
- Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California
| |
Collapse
|
12
|
Zhelev Z, Peters J, Rogers M, Allen M, Kijauskaite G, Seedat F, Wilkinson E, Hyde C. Test accuracy of artificial intelligence-based grading of fundus images in diabetic retinopathy screening: A systematic review. J Med Screen 2023; 30:97-112. [PMID: 36617971 PMCID: PMC10399100 DOI: 10.1177/09691413221144382] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2022] [Revised: 11/14/2022] [Accepted: 11/18/2022] [Indexed: 01/10/2023]
Abstract
OBJECTIVES To systematically review the accuracy of artificial intelligence (AI)-based systems for grading of fundus images in diabetic retinopathy (DR) screening. METHODS We searched MEDLINE, EMBASE, the Cochrane Library and the ClinicalTrials.gov from 1st January 2000 to 27th August 2021. Accuracy studies published in English were included if they met the pre-specified inclusion criteria. Selection of studies for inclusion, data extraction and quality assessment were conducted by one author with a second reviewer independently screening and checking 20% of titles. Results were analysed narratively. RESULTS Forty-three studies evaluating 15 deep learning (DL) and 4 machine learning (ML) systems were included. Nine systems were evaluated in a single study each. Most studies were judged to be at high or unclear risk of bias in at least one QUADAS-2 domain. Sensitivity for referable DR and higher grades was ≥85% while specificity varied and was <80% for all ML systems and in 6/31 studies evaluating DL systems. Studies reported high accuracy for detection of ungradable images, but the latter were analysed and reported inconsistently. Seven studies reported that AI was more sensitive but less specific than human graders. CONCLUSIONS AI-based systems are more sensitive than human graders and could be safe to use in clinical practice but have variable specificity. However, for many systems evidence is limited, at high risk of bias and may not generalise across settings. Therefore, pre-implementation assessment in the target clinical pathway is essential to obtain reliable and applicable accuracy estimates.
Collapse
Affiliation(s)
- Zhivko Zhelev
- Exeter Test Group, University of Exeter Medical School, University of Exeter, Exeter, UK
| | - Jaime Peters
- Exeter Test Group, University of Exeter Medical School, University of Exeter, Exeter, UK
| | - Morwenna Rogers
- NIHR ARC South West Peninsula (PenARC), University of Exeter Medical School, University of Exeter, Exeter, UK
| | - Michael Allen
- University of Exeter Medical School, University of Exeter, Exeter, UK
| | | | | | | | - Christopher Hyde
- Exeter Test Group, University of Exeter Medical School, University of Exeter, Exeter, UK
| |
Collapse
|
13
|
Oganov AC, Seddon I, Jabbehdari S, Uner OE, Fonoudi H, Yazdanpanah G, Outani O, Arevalo JF. Artificial intelligence in retinal image analysis: Development, advances, and challenges. Surv Ophthalmol 2023; 68:905-919. [PMID: 37116544 DOI: 10.1016/j.survophthal.2023.04.001] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2022] [Revised: 04/20/2023] [Accepted: 04/24/2023] [Indexed: 04/30/2023]
Abstract
Modern advances in diagnostic technologies offer the potential for unprecedented insight into ophthalmic conditions relating to the retina. We discuss the current landscape of artificial intelligence in retina with respect to screening, diagnosis, and monitoring of retinal pathologies such as diabetic retinopathy, diabetic macular edema, central serous chorioretinopathy, and age-related macular degeneration. We review the methods used in these models and evaluate their performance in both research and clinical contexts and discuss potential future directions for investigation, use of multiple imaging modalities in artificial intelligence algorithms, and challenges in the application of artificial intelligence in retinal pathologies.
Collapse
Affiliation(s)
- Anthony C Oganov
- Department of Ophthalmology, Renaissance School of Medicine, Stony Brook, NY, USA
| | - Ian Seddon
- College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL, USA
| | - Sayena Jabbehdari
- Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
| | - Ogul E Uner
- Casey Eye Institute, Department of Ophthalmology, Oregon Health and Science University, Portland, OR, USA
| | - Hossein Fonoudi
- Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Iranshahr University of Medical Sciences, Iranshahr, Sistan and Baluchestan, Iran
| | - Ghasem Yazdanpanah
- Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, IL, USA
| | - Oumaima Outani
- Faculty of Medicine and Pharmacy of Rabat, Mohammed 5 University, Rabat, Rabat, Morocco
| | - J Fernando Arevalo
- Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| |
Collapse
|
14
|
Gomes RFT, Schuch LF, Martins MD, Honório EF, de Figueiredo RM, Schmith J, Machado GN, Carrard VC. Use of Deep Neural Networks in the Detection and Automated Classification of Lesions Using Clinical Images in Ophthalmology, Dermatology, and Oral Medicine-A Systematic Review. J Digit Imaging 2023; 36:1060-1070. [PMID: 36650299 PMCID: PMC10287602 DOI: 10.1007/s10278-023-00775-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2022] [Revised: 01/03/2023] [Accepted: 01/04/2023] [Indexed: 01/19/2023] Open
Abstract
Artificial neural networks (ANN) are artificial intelligence (AI) techniques used in the automated recognition and classification of pathological changes from clinical images in areas such as ophthalmology, dermatology, and oral medicine. The combination of enterprise imaging and AI is gaining notoriety for its potential benefits in healthcare areas such as cardiology, dermatology, ophthalmology, pathology, physiatry, radiation oncology, radiology, and endoscopic. The present study aimed to analyze, through a systematic literature review, the application of performance of ANN and deep learning in the recognition and automated classification of lesions from clinical images, when comparing to the human performance. The PRISMA 2020 approach (Preferred Reporting Items for Systematic Reviews and Meta-analyses) was used by searching four databases of studies that reference the use of IA to define the diagnosis of lesions in ophthalmology, dermatology, and oral medicine areas. A quantitative and qualitative analyses of the articles that met the inclusion criteria were performed. The search yielded the inclusion of 60 studies. It was found that the interest in the topic has increased, especially in the last 3 years. We observed that the performance of IA models is promising, with high accuracy, sensitivity, and specificity, most of them had outcomes equivalent to human comparators. The reproducibility of the performance of models in real-life practice has been reported as a critical point. Study designs and results have been progressively improved. IA resources have the potential to contribute to several areas of health. In the coming years, it is likely to be incorporated into everyday life, contributing to the precision and reducing the time required by the diagnostic process.
Collapse
Affiliation(s)
- Rita Fabiane Teixeira Gomes
- Graduate Program in Dentistry, School of Dentistry, Federal University of Rio Grande Do Sul, Barcelos 2492/503, Bairro Santana, Porto Alegre, RS, CEP 90035-003, Brazil.
| | - Lauren Frenzel Schuch
- Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas, Piracicaba, Brazil
| | - Manoela Domingues Martins
- Graduate Program in Dentistry, School of Dentistry, Federal University of Rio Grande Do Sul, Barcelos 2492/503, Bairro Santana, Porto Alegre, RS, CEP 90035-003, Brazil
- Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas, Piracicaba, Brazil
| | | | - Rodrigo Marques de Figueiredo
- Technology in Automation and Electronics Laboratory - TECAE Lab, University of Vale Do Rio Dos Sinos - UNISINOS, São Leopoldo, Brazil
| | - Jean Schmith
- Technology in Automation and Electronics Laboratory - TECAE Lab, University of Vale Do Rio Dos Sinos - UNISINOS, São Leopoldo, Brazil
| | - Giovanna Nunes Machado
- Technology in Automation and Electronics Laboratory - TECAE Lab, University of Vale Do Rio Dos Sinos - UNISINOS, São Leopoldo, Brazil
| | - Vinicius Coelho Carrard
- Graduate Program in Dentistry, School of Dentistry, Federal University of Rio Grande Do Sul, Barcelos 2492/503, Bairro Santana, Porto Alegre, RS, CEP 90035-003, Brazil
- Department of Epidemiology, School of Medicine, TelessaúdeRS-UFRGS, Federal University of Rio Grande Do Sul, Porto Alegre, RS, Brazil
- Department of Oral Medicine, Otorhinolaryngology Service, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil
| |
Collapse
|
15
|
Vaghefi E, Yang S, Xie L, Han D, Yap A, Schmeidel O, Marshall J, Squirrell D. A multi-centre prospective evaluation of THEIA™ to detect diabetic retinopathy (DR) and diabetic macular oedema (DMO) in the New Zealand screening program. Eye (Lond) 2023; 37:1683-1689. [PMID: 36057664 PMCID: PMC10219993 DOI: 10.1038/s41433-022-02217-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2021] [Revised: 07/09/2022] [Accepted: 08/12/2022] [Indexed: 12/23/2022] Open
Abstract
PURPOSE To validate the potential application of THEIA™ as clinical decision making assistant in a national screening program. METHODS A total of 900 patients were recruited from either an urban large eye hospital, or a semi-rural optometrist led screening provider, as they were attending their appointment as part of New Zealand Diabetic Eye Screening Programme. The de-identified images were independently graded by three senior specialists, and final results were aggregated using New Zealand grading scheme, which was then converted to referable/non-referable and Healthy/mild/more than mild/sight threatening categories. RESULTS THEIA™ managed to grade all images obtained during the study. Comparing the adjudicated images from the specialist grading team, "ground truth", with the grading by the AI platform in detecting "sight threatening" disease, at the patient level THEIA™ achieved 100% imageability, 100% [98.49-100.00%] sensitivity and [97.02-99.16%] specificity, and negative predictive value of 100%. In other words, THEIA™ did not miss any patients with "more than mild" or "sight threatening" disease. The level of agreement between the clinicians and the aggregated results was (k value: 0.9881, 0.9557, and 0.9175), and the level of agreement between THEIA™ and the aggregated labels was (k value: 0.9515). CONCLUSION This multi-centre prospective trial showed that THEIA™ did not miss referable disease when screening for diabetic retinopathy and maculopathy. It also had a very high level of granularity in reporting the disease level. As THEIA™ has been tested on a variety of cameras, operating in a range of clinics (rural/urban, ophthalmologist-led\optometrist-led), we believe that it will be a suitable addition to a public diabetic screening program.
Collapse
Affiliation(s)
- Ehsan Vaghefi
- Toku Eyes®, Auckland, New Zealand.
- School of Optometry and Vision Science, The University of Auckland, Auckland, New Zealand.
| | | | - Li Xie
- Toku Eyes®, Auckland, New Zealand
| | | | - Aaron Yap
- Department of Ophthalmology, The University of Auckland, Auckland, New Zealand
| | - Ole Schmeidel
- Department of Diabetes, Auckland District Health Board, Auckland, New Zealand
| | - John Marshall
- Institute of Ophthalmology, University College of London, London, UK
| | - David Squirrell
- Toku Eyes®, Auckland, New Zealand
- Department of Ophthalmology, The University of Auckland, Auckland, New Zealand
| |
Collapse
|
16
|
Canelo Moreno JM, Gros Herguido N, De Lara Rodríguez I, González Navarro I, Mangas Cruz MÁ, Muñoz Morales A, Santacruz Alvarez P, Ruiz Trillo C, Soto Moreno A. Telemedicine screening program for diabetic retinopathy in patients with type 1 diabetes mellitus. ENDOCRINOL DIAB NUTR 2023; 70:196-201. [PMID: 37030901 DOI: 10.1016/j.endien.2023.03.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/16/2022] [Accepted: 11/20/2022] [Indexed: 04/10/2023]
Abstract
PURPOSE To analyze the results of the telemedicine screening program for diabetic retinopathy (DR) in patients with type 1 diabetes conducted by the Endocrinology and Nutrition Management Unit of Virgen del Rocío University Hospital. METHODS This cross-sectional study comprised patients with type 1 diabetes mellitus (DM) in our DR screening program from January 2018 to November 2020. Fundus photographs are performed by trained nurses and reviewed by a trained endocrinologist. Those suggestive of pathology are sent to ophthalmology through a telematic program for review. RESULTS Of the 995 fundus photographs evaluated, 646 (65.3%) showed no evidence of DR, 327 (33.1%) presented possible DR, and 16 (1.6%) were not gradable. The diagnosis was confirmed in 254 patients after reviewing by ophthalmology, and the screening program achieved a positive predictive value for DR of 77.7%. Seventy-three were excluded by ophthalmology due to the absence of DR (false positive rate - 22.3%). In 92.5% of the cases classified by the ophthalmologist, the degree of DR was mild or very mild. CONCLUSION Our telemedicine screening program for DR in patients with type 1 DM is consistent with the literature. Effective screening for DR is performed, with patients diagnosed in the early stages. Telemedicine programs facilitate efficient communication among healthcare personnel.
Collapse
Affiliation(s)
| | - Noelia Gros Herguido
- Endocrinology and Nutrition Management Unit, Virgen del Rocío University Hospital, Seville, Spain
| | - Irene De Lara Rodríguez
- Endocrinology and Nutrition Management Unit, Virgen del Rocío University Hospital, Seville, Spain
| | - Irene González Navarro
- Endocrinology and Nutrition Management Unit, Virgen del Rocío University Hospital, Seville, Spain
| | - Miguel Ángel Mangas Cruz
- Endocrinology and Nutrition Management Unit, Virgen del Rocío University Hospital, Seville, Spain
| | - Ana Muñoz Morales
- Ophthalmology Management Unit, Virgen del Rocío University Hospital, Seville, Spain
| | - Pilar Santacruz Alvarez
- Endocrinology and Nutrition Management Unit, Virgen del Rocío University Hospital, Seville, Spain
| | - Carmen Ruiz Trillo
- Endocrinology and Nutrition Management Unit, Virgen del Rocío University Hospital, Seville, Spain
| | - Alfonso Soto Moreno
- Endocrinology and Nutrition Management Unit, Virgen del Rocío University Hospital, Seville, Spain
| |
Collapse
|
17
|
Horie S, Ohno-Matsui K. Progress of Imaging in Diabetic Retinopathy-From the Past to the Present. Diagnostics (Basel) 2022; 12:diagnostics12071684. [PMID: 35885588 PMCID: PMC9319818 DOI: 10.3390/diagnostics12071684] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2022] [Revised: 06/24/2022] [Accepted: 07/06/2022] [Indexed: 02/05/2023] Open
Abstract
Advancement of imaging technology in retinal diseases provides us more precise understanding and new insights into the diseases' pathologies. Diabetic retinopathy (DR) is one of the leading causes of sight-threatening retinal diseases worldwide. Colour fundus photography and fluorescein angiography have long been golden standard methods in detecting retinal vascular pathology in this disease. One of the major advancements is macular observation given by optical coherence tomography (OCT). OCT dramatically improves the diagnostic quality in macular edema in DR. The technology of OCT is also applied to angiography (OCT angiograph: OCTA), which enables retinal vascular imaging without venous dye injection. Similar to OCTA, in terms of their low invasiveness, single blue color SLO image could be an alternative method in detecting non-perfused areas. Conventional optical photography has been gradually replaced to scanning laser ophthalmoscopy (SLO), which also make it possible to produce spectacular ultra-widefield (UWF) images. Since retinal vascular changes of DR are found in the whole retina up to periphery, it would be one of the best targets in UWF imaging. Additionally, evolvement of artificial intelligence (AI) has been applied to automated diagnosis of DR, and AI-based DR management is one of the major topics in this field. This review is trying to look back on the progress of imaging of DR comprehensively from the past to the present.
Collapse
Affiliation(s)
- Shintaro Horie
- Department of Advanced Ophthalmic Imaging, Tokyo Medical and Dental University, Tokyo 113-8519, Japan;
| | - Kyoko Ohno-Matsui
- Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo 113-8519, Japan
- Correspondence: ; Tel.: +81-3-5803-5302
| |
Collapse
|
18
|
Malerbi FK, Andrade RE, Morales PH, Stuchi JA, Lencione D, de Paulo JV, Carvalho MP, Nunes FS, Rocha RM, Ferraz DA, Belfort R. Diabetic Retinopathy Screening Using Artificial Intelligence and Handheld Smartphone-Based Retinal Camera. J Diabetes Sci Technol 2022; 16:716-723. [PMID: 33435711 PMCID: PMC9294565 DOI: 10.1177/1932296820985567] [Citation(s) in RCA: 28] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
BACKGROUND Portable retinal cameras and deep learning (DL) algorithms are novel tools adopted by diabetic retinopathy (DR) screening programs. Our objective is to evaluate the diagnostic accuracy of a DL algorithm and the performance of portable handheld retinal cameras in the detection of DR in a large and heterogenous type 2 diabetes population in a real-world, high burden setting. METHOD Participants underwent fundus photographs of both eyes with a portable retinal camera (Phelcom Eyer). Classification of DR was performed by human reading and a DL algorithm (PhelcomNet), consisting of a convolutional neural network trained on a dataset of fundus images captured exclusively with the portable device; both methods were compared. We calculated the area under the curve (AUC), sensitivity, and specificity for more than mild DR. RESULTS A total of 824 individuals with type 2 diabetes were enrolled at Itabuna Diabetes Campaign, a subset of 679 (82.4%) of whom could be fully assessed. The algorithm sensitivity/specificity was 97.8 % (95% CI 96.7-98.9)/61.4 % (95% CI 57.7-65.1); AUC was 0·89. All false negative cases were classified as moderate non-proliferative diabetic retinopathy (NPDR) by human grading. CONCLUSIONS The DL algorithm reached a good diagnostic accuracy for more than mild DR in a real-world, high burden setting. The performance of the handheld portable retinal camera was adequate, with over 80% of individuals presenting with images of sufficient quality. Portable devices and artificial intelligence tools may increase coverage of DR screening programs.
Collapse
Affiliation(s)
- Fernando Korn Malerbi
- Department of Ophthalmology and Visual
Sciences, Federal University of São Paulo, São Paulo, Brazil
- Instituto Paulista de Estudos e
Pesquisas em Oftalmologia, IPEPO, Vision Institute, São Paulo, Brazil
- Fernando Korn Malerbi, Federal University of
São Paulo, Rua Botucatu, 822. São Paulo, SP 04039-032, Brazil.
| | - Rafael Ernane Andrade
- Department of Ophthalmology and Visual
Sciences, Federal University of São Paulo, São Paulo, Brazil
- Hospital de Olhos Beira Rio, Itabuna,
BA, Brazil
| | - Paulo Henrique Morales
- Department of Ophthalmology and Visual
Sciences, Federal University of São Paulo, São Paulo, Brazil
- Instituto Paulista de Estudos e
Pesquisas em Oftalmologia, IPEPO, Vision Institute, São Paulo, Brazil
| | | | | | | | | | | | | | - Daniel A. Ferraz
- Instituto Paulista de Estudos e
Pesquisas em Oftalmologia, IPEPO, Vision Institute, São Paulo, Brazil
- NIHR Biomedical Research Centre for
Ophthalmology, Moorfields Eye Hospital, NHS Foundation Trust and UCL Institute of
Ophthalmology, London, UK
| | - Rubens Belfort
- Department of Ophthalmology and Visual
Sciences, Federal University of São Paulo, São Paulo, Brazil
- Instituto Paulista de Estudos e
Pesquisas em Oftalmologia, IPEPO, Vision Institute, São Paulo, Brazil
| |
Collapse
|
19
|
Sedova A, Hajdu D, Datlinger F, Steiner I, Neschi M, Aschauer J, Gerendas BS, Schmidt-Erfurth U, Pollreisz A. Comparison of early diabetic retinopathy staging in asymptomatic patients between autonomous AI-based screening and human-graded ultra-widefield colour fundus images. Eye (Lond) 2022; 36:510-516. [PMID: 35132211 PMCID: PMC8873196 DOI: 10.1038/s41433-021-01912-4] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2021] [Revised: 11/02/2021] [Accepted: 12/16/2021] [Indexed: 02/01/2023] Open
Abstract
INTRODUCTION Comparison of diabetic retinopathy (DR) severity between autonomous Artificial Intelligence (AI)-based outputs from an FDA-approved screening system and human retina specialists' gradings from ultra-widefield (UWF) colour images. METHODS Asymptomatic diabetics without a previous diagnosis of DR were included in this prospective observational pilot study. Patients were imaged with autonomous AI (IDx-DR, Digital Diagnostics). For each eye, two 45° colour fundus images were analysed by a secure server-based AI algorithm. UWF colour fundus imaging was performed using Optomap (Daytona, Optos). The International Clinical DR severity score was assessed both on a 7-field area projection (7F-mask) according to the early treatment diabetic retinopathy study (ETDRS) and on the total gradable area (UWF full-field) up to the far periphery on UWF images. RESULTS Of 54 patients included (n = 107 eyes), 32 were type 2 diabetics (11 females). Mean BCVA was 0.99 ± 0.25. Autonomous AI diagnosed 16 patients as negative, 28 for moderate DR and 10 for having a vision-threatening disease (severe DR, proliferative DR, diabetic macular oedema). Based on the 7F-mask grading with the eye with the worse grading defining the DR stage 23 patients were negative for DR, 11 showed mild, 19 moderate and 1 severe DR. When UWF full-field was analysed, 20 patients were negative for DR, while the number of mild, moderate and severe DR patients were 12, 21, and 1, respectively. CONCLUSIONS The autonomous AI-based DR examination demonstrates sufficient accuracy in diagnosing asymptomatic non-proliferative diabetic patients with referable DR even compared to UWF imaging evaluated by human experts offering a suitable method for DR screening.
Collapse
Affiliation(s)
- Aleksandra Sedova
- Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria
| | - Dorottya Hajdu
- Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria
| | - Felix Datlinger
- Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria
| | - Irene Steiner
- Center for Medical Statistics, Informatics and Intelligent Systems, Section for Medical Statistics, Medical University of Vienna, Vienna, Austria
| | - Martina Neschi
- Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria
| | - Julia Aschauer
- Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria
| | - Bianca S Gerendas
- Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria
| | - Ursula Schmidt-Erfurth
- Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria
| | - Andreas Pollreisz
- Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
| |
Collapse
|
20
|
Huang XM, Yang BF, Zheng WL, Liu Q, Xiao F, Ouyang PW, Li MJ, Li XY, Meng J, Zhang TT, Cui YH, Pan HW. Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China. BMC Health Serv Res 2022; 22:260. [PMID: 35216586 PMCID: PMC8881835 DOI: 10.1186/s12913-022-07655-6] [Citation(s) in RCA: 28] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2021] [Accepted: 02/16/2022] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Diabetic retinopathy (DR) has become a leading cause of global blindness as a microvascular complication of diabetes. Regular screening of diabetic retinopathy is strongly recommended for people with diabetes so that timely treatment can be provided to reduce the incidence of visual impairment. However, DR screening is not well carried out due to lack of eye care facilities, especially in the rural areas of China. Artificial intelligence (AI) based DR screening has emerged as a novel strategy and show promising diagnostic performance in sensitivity and specificity, relieving the pressure of the shortage of facilities and ophthalmologists because of its quick and accurate diagnosis. In this study, we estimated the cost-effectiveness of AI screening for DR in rural China based on Markov model, providing evidence for extending use of AI screening for DR. METHODS We estimated the cost-effectiveness of AI screening and compared it with ophthalmologist screening in which fundus images are evaluated by ophthalmologists. We developed a Markov model-based hybrid decision tree to analyze the costs, effectiveness and incremental cost-effectiveness ratio (ICER) of AI screening strategies relative to no screening strategies and ophthalmologist screening strategies (dominated) over 35 years (mean life expectancy of diabetes patients in rural China). The analysis was conducted from the health system perspective (included direct medical costs) and societal perspective (included medical and nonmedical costs). Effectiveness was analyzed with quality-adjusted life years (QALYs). The robustness of results was estimated by performing one-way sensitivity analysis and probabilistic analysis. RESULTS From the health system perspective, AI screening and ophthalmologist screening had incremental costs of $180.19 and $215.05 but more quality-adjusted life years (QALYs) compared with no screening. AI screening had an ICER of $1,107.63. From the societal perspective which considers all direct and indirect costs, AI screening had an ICER of $10,347.12 compared with no screening, below the cost-effective threshold (1-3 times per capita GDP of Chinese in 2019). CONCLUSIONS Our analysis demonstrates that AI-based screening is more cost-effective compared with conventional ophthalmologist screening and holds great promise to be an alternative approach for DR screening in the rural area of China.
Collapse
Affiliation(s)
- Xiao-Mei Huang
- Department of Ophthalmology, the First Affiliated Hospital, Jinan University, Guangzhou, China.,Institute of Ophthalmology, School of Medicine, Jinan University, Guangzhou, China
| | - Bo-Fan Yang
- Institute of Ophthalmology, School of Medicine, Jinan University, Guangzhou, China
| | - Wen-Lin Zheng
- Institute of Ophthalmology, School of Medicine, Jinan University, Guangzhou, China.,Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China
| | - Qun Liu
- Institute of Ophthalmology, School of Medicine, Jinan University, Guangzhou, China
| | - Fan Xiao
- Institute of Ophthalmology, School of Medicine, Jinan University, Guangzhou, China.,Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China
| | - Pei-Wen Ouyang
- Department of Ophthalmology, the First Affiliated Hospital, Jinan University, Guangzhou, China.,Institute of Ophthalmology, School of Medicine, Jinan University, Guangzhou, China
| | - Mei-Jun Li
- Department of Ophthalmology, the First Affiliated Hospital, Jinan University, Guangzhou, China.,Institute of Ophthalmology, School of Medicine, Jinan University, Guangzhou, China
| | - Xiu-Yun Li
- Department of Ophthalmology, Affiliated Hospital of Weifang Medical University, Weifang, China
| | - Jing Meng
- Department of Ophthalmology, the First Affiliated Hospital, Jinan University, Guangzhou, China
| | | | - Yu-Hong Cui
- School of Basic Medical Sciences, The Guangzhou Institute of Cardiovascular Disease, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.,Department of Histology and Embryology, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China
| | - Hong-Wei Pan
- Department of Ophthalmology, the First Affiliated Hospital, Jinan University, Guangzhou, China. .,Institute of Ophthalmology, School of Medicine, Jinan University, Guangzhou, China.
| |
Collapse
|
21
|
Kaymak H, Neller K, Graff B, Körgesaar K, Langenbucher A, Seitz B, Schwahn H. [Optometric eye screening in schools : First epidemiological data for children and adolescents in grades 5-7]. Ophthalmologe 2022; 119:33-40. [PMID: 34114061 PMCID: PMC8191721 DOI: 10.1007/s00347-021-01427-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2021] [Revised: 05/09/2021] [Accepted: 05/10/2021] [Indexed: 11/11/2022]
Abstract
BACKGROUND Annually recurring optometric screening helps to identify children with increased axial growth and also to create awareness for wearing properly corrected glasses and for spending enough time outdoors, both of which are crucial for healthy eyes. The obtained biometric data help to expand the epidemiological information on myopia in schoolchildren, which is fundamental for the selection of the correct treatment. MATERIAL AND METHODS Contact-free biometry of the eye was used to assess central corneal thickness, anterior chamber depth, lens thickness and axial length. Central choroidal thickness was manually assessed using optical coherence tomography (OCT). In addition, the mesopic and photopic pupil sizes were measured. RESULTS Biometric data were obtained from 257 (mean age 11.2 ± 1.1 years, 31.9% female, n = 82, 68.1% male, n = 175) out of a total of 274 examined children. Mean corneal radius (mean ± SD, female/male) was 7.74 ± 0.23 mm/7.89 ± 0.22 mm, central corneal thickness was 556.80 ± 31.31 µm/565.68 ± 33.12 µm, anterior chamber depth was 3.62 ± 0.28 mm/3.71 ± 0.25 mm, lens thickness was 3.48 ± 0.18 mm/3.46 ± 0.17 mm and axial length was 23.03 ± 0.88 mm/23.51 ± 0.88 mm. Choroidal thickness was assessed in 240 children and was 335.12 ± 60.5 µm. Mesopic and photopic pupil sizes were 6.38 ± 0.70 mm and 3.11 ± 0.63 mm, respectively. CONCLUSION The axial lengths found are consistent with the normal values for European children. A difference between male and female eyes could be observed. The repetition of these examinations in the future will enable the generation of growth charts.
Collapse
Affiliation(s)
- Hakan Kaymak
- Institut für Experimentelle Ophthalmologie, Universitätsklinikum des Saarlandes UKS, Homburg/Saar, Deutschland.
- Internationale Innovative Ophthalmochirurgie, Breyer Kaymak Klabe Augenchirurgie, Düsseldorf, Deutschland.
| | - Kai Neller
- Institut für Experimentelle Ophthalmologie, Universitätsklinikum des Saarlandes UKS, Homburg/Saar, Deutschland
- Internationale Innovative Ophthalmochirurgie, Breyer Kaymak Klabe Augenchirurgie, Düsseldorf, Deutschland
| | - Birte Graff
- Institut für Experimentelle Ophthalmologie, Universitätsklinikum des Saarlandes UKS, Homburg/Saar, Deutschland
- Internationale Innovative Ophthalmochirurgie, Breyer Kaymak Klabe Augenchirurgie, Düsseldorf, Deutschland
| | | | - Achim Langenbucher
- Institut für Experimentelle Ophthalmologie, Universitätsklinikum des Saarlandes UKS, Homburg/Saar, Deutschland
| | - Berthold Seitz
- Klinik für Augenheilkunde, Universitätsklinikum des Saarlandes UKS, Homburg/Saar, Deutschland
| | - Hartmut Schwahn
- Internationale Innovative Ophthalmochirurgie, Breyer Kaymak Klabe Augenchirurgie, Düsseldorf, Deutschland
| |
Collapse
|
22
|
Jimenez-Carmona S, Alemany-Marquez P, Alvarez-Ramos P, Mayoral E, Aguilar-Diosdado M. Validation of an Automated Screening System for Diabetic Retinopathy Operating under Real Clinical Conditions. J Clin Med 2021; 11:jcm11010014. [PMID: 35011754 PMCID: PMC8745311 DOI: 10.3390/jcm11010014] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2021] [Revised: 12/13/2021] [Accepted: 12/16/2021] [Indexed: 12/12/2022] Open
Abstract
Background. Retinopathy is the most common microvascular complication of diabetes mellitus. It is the leading cause of blindness among working-aged people in developed countries. The use of telemedicine in the screening system has enabled the application of large-scale population-based programs for early retinopathy detection in diabetic patients. However, the need to support ophthalmologists with other trained personnel remains a barrier to broadening its implementation. Methods. Automatic diagnosis of diabetic retinopathy was carried out through the analysis of retinal photographs using the 2iRetinex software. We compared the categorical diagnoses of absence/presence of retinopathy issued by family physicians (PCP) with the same categories provided by the algorithm (ALG). The agreed diagnosis of three specialist ophthalmologists is used as the reference standard (OPH). Results. There were 653 of 3520 patients diagnosed with diabetic retinopathy (DR). Diabetic retinopathy threatening to vision (STDR) was found in 82 patients (2.3%). Diagnostic sensitivity for STDR was 94% (ALG) and 95% (PCP). No patient with proliferating or severe DR was misdiagnosed in both strategies. The k-value of the agreement between the ALG and OPH was 0.5462, while between PCP and OPH was 0.5251 (p = 0.4291). Conclusions. The diagnostic capacity of 2iRetinex operating under normal clinical conditions is comparable to screening physicians.
Collapse
Affiliation(s)
- Soledad Jimenez-Carmona
- Ophthalmology Department, Hospital Universitario Puerta del Mar, University of Cadiz, 11009 Cadiz, Spain;
- Correspondence: (S.J.-C.); (P.A.-M.)
| | - Pedro Alemany-Marquez
- Ophthalmology Department, Hospital Universitario Puerta del Mar, University of Cadiz, 11009 Cadiz, Spain;
- Correspondence: (S.J.-C.); (P.A.-M.)
| | - Pablo Alvarez-Ramos
- Ophthalmology Department, Hospital Universitario Puerta del Mar, University of Cadiz, 11009 Cadiz, Spain;
| | - Eduardo Mayoral
- Comprehensive Healthcare Plan for Diabetes, Regional Ministry of Health and Families of Andalusia, Government of Andalusia, 41020 Seville, Spain;
| | | |
Collapse
|
23
|
Wang Y, Shi D, Tan Z, Niu Y, Jiang Y, Xiong R, Peng G, He M. Screening Referable Diabetic Retinopathy Using a Semi-automated Deep Learning Algorithm Assisted Approach. Front Med (Lausanne) 2021; 8:740987. [PMID: 34901058 PMCID: PMC8656222 DOI: 10.3389/fmed.2021.740987] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2021] [Accepted: 11/08/2021] [Indexed: 12/23/2022] Open
Abstract
Purpose: To assess the accuracy and efficacy of a semi-automated deep learning algorithm (DLA) assisted approach to detect vision-threatening diabetic retinopathy (DR). Methods: We developed a two-step semi-automated DLA-assisted approach to grade fundus photographs for vision-threatening referable DR. Study images were obtained from the Lingtou Cohort Study, and captured at participant enrollment in 2009–2010 (“baseline images”) and annual follow-up between 2011 and 2017. To begin, a validated DLA automatically graded baseline images for referable DR and classified them as positive, negative, or ungradable. Following, each positive image, all other available images from patients who had a positive image, and a 5% random sample of all negative images were selected and regraded by trained human graders. A reference standard diagnosis was assigned once all graders achieved consistent grading outcomes or with a senior ophthalmologist's final diagnosis. The semi-automated DLA assisted approach combined initial DLA screening and subsequent human grading for images identified as high-risk. This approach was further validated within the follow-up image datasets and its time and economic costs evaluated against fully human grading. Results: For evaluation of baseline images, a total of 33,115 images were included and automatically graded by the DLA. 2,604 images (480 positive results, 624 available other images from participants with a positive result, and 1500 random negative samples) were selected and regraded by graders. The DLA achieved an area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and accuracy of 0.953, 0.970, 0.879, and 88.6%, respectively. In further validation within the follow-up image datasets, a total of 88,363 images were graded using this semi-automated approach and human grading was performed on 8975 selected images. The DLA achieved an AUC, sensitivity, and specificity of 0.914, 0.852, 0.853, respectively. Compared against fully human grading, the semi-automated DLA-assisted approach achieved an estimated 75.6% time and 90.1% economic cost saving. Conclusions: The DLA described in this study was able to achieve high accuracy, sensitivity, and specificity in grading fundus images for referable DR. Validated against long-term follow-up datasets, a semi-automated DLA-assisted approach was able to accurately identify suspect cases, and minimize misdiagnosis whilst balancing safety, time, and economic cost.
Collapse
Affiliation(s)
- Yueye Wang
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
| | - Danli Shi
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
| | - Zachary Tan
- Centre for Eye Research Australia, University of Melbourne, Melbourne, VIC, Australia
| | - Yong Niu
- Department of Ophthalmology, Guangzhou No. 11 People's Hospital, Guangzhou, China
| | - Yu Jiang
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
| | - Ruilin Xiong
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
| | - Guankai Peng
- Guangzhou Vision Tech Medical Technology Co. Ltd., Guangzhou, China
| | - Mingguang He
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.,Centre for Eye Research Australia, University of Melbourne, Melbourne, VIC, Australia.,Department of Ophthalmology, Guangdong Eye Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.,Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, VIC, Australia
| |
Collapse
|
24
|
Gayathri S, Gopi VP, Palanisamy P. Diabetic retinopathy classification based on multipath CNN and machine learning classifiers. Phys Eng Sci Med 2021; 44:639-653. [PMID: 34033015 DOI: 10.1007/s13246-021-01012-3] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2020] [Accepted: 05/06/2021] [Indexed: 11/28/2022]
Abstract
Eye care professionals generally use fundoscopy to confirm the occurrence of Diabetic Retinopathy (DR) in patients. Early DR detection and accurate DR grading are critical for the care and management of this disease. This work proposes an automated DR grading method in which features can be extracted from the fundus images and categorized based on severity using deep learning and Machine Learning (ML) algorithms. A Multipath Convolutional Neural Network (M-CNN) is used for global and local feature extraction from images. Then, a machine learning classifier is used to categorize the input according to the severity. The proposed model is evaluated across different publicly available databases (IDRiD, Kaggle (for DR detection), and MESSIDOR) and different ML classifiers (Support Vector Machine (SVM), Random Forest, and J48). The metrics selected for model evaluation are the False Positive Rate (FPR), Specificity, Precision, Recall, F1-score, K-score, and Accuracy. The experiments show that the best response is produced by the M-CNN network with the J48 classifier. The classifiers are evaluated across the pre-trained network features and existing DR grading methods. The average accuracy obtained for the proposed work is 99.62% for DR grading. The experiments and evaluation results show that the proposed method works well for accurate DR grading and early disease detection.
Collapse
Affiliation(s)
- S Gayathri
- National Institute of Technology, Tiruchirappalli, Tamil Nadu, India
| | - Varun P Gopi
- National Institute of Technology, Tiruchirappalli, Tamil Nadu, India.
| | - P Palanisamy
- National Institute of Technology, Tiruchirappalli, Tamil Nadu, India
| |
Collapse
|
25
|
Kim HS, Kwon IH, Cha WC. Future and Development Direction of Digital Healthcare. Healthc Inform Res 2021; 27:95-101. [PMID: 34015874 PMCID: PMC8137879 DOI: 10.4258/hir.2021.27.2.95] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2021] [Accepted: 01/19/2021] [Indexed: 11/23/2022] Open
Abstract
OBJECTIVES Digital healthcare is expected to play a pivotal role in patient-centered healthcare. It empowers patients by informing, communicating, and motivating them. However, a pragmatic evaluation of the present status of digital healthcare has not been presented; therefore, we aimed to examine the status of digital healthcare in Korea. METHODS This article discusses digital healthcare, examples of assessment in Korea and other countries, the implications of past examples, and future directions for development. RESULTS Over the years, various clinical studies have used clinical evidence to assess the feasibility of digital healthcare. If feasible, it is actually clinically effective. If it is effective, can it be commercialized at an acceptable cost? These questions have been investigated in various evidence-based studies. In addition, great efforts are being made to secure ample evidence to assess various aspects of digital healthcare, such as safety, quality, end-user experience, and equity. CONCLUSIONS Digital healthcare requires a deep understanding of both the technical and medical aspects. To strengthen the competence of the medical aspect, medical staff, patients, and the government must work together with continuous interest in this goal.
Collapse
Affiliation(s)
- Hun-Sung Kim
- Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Korea.,Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
| | - In Ho Kwon
- Department of Emergency Medicine, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Korea
| | - Won Chul Cha
- Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, Korea.,Department of Emergency Medicine, Samsung Medical Center, Seoul, Korea.,Digital Innovation Center, Samsung Medical Center, Seoul, Korea
| |
Collapse
|
26
|
Straňák Z, Penčák M, Veith M. ARTEFICIAL INTELLIGENCE IN DIABETIC RETINOPATHY SCREENING. A REVIEW. CESKA A SLOVENSKA OFTALMOLOGIE : CASOPIS CESKE OFTALMOLOGICKE SPOLECNOSTI A SLOVENSKE OFTALMOLOGICKE SPOLECNOSTI 2021; 77:224-231. [PMID: 34666491 DOI: 10.31348/2021/6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
OBJECTIVE The aim of this comprehensive paper is to acquaint the readers with evaluation of the retinal images using the arteficial intelligence (AI). Main focus of the paper is diabetic retinophaty (DR) screening. The basic principles of the artificial intelligence and algorithms that are already used in clinical practice or are shortly before approval will be described. METHODOLOGY Describing the basic characteristics and mechanisms of different approaches to the use of AI and subsequently literary minireview clarifying the current state of knowledge in the area. RESULTS Modern systems for screening diabetic retinopathy using deep neural networks achieve a sensitivity and specificity of over 80 % in most published studies. The results of specific studies vary depending on the definition of the gold standard, number of images tested and on the evaluated parameters. CONCLUSION Evaluation of images using AI will speed up and streamline the diagnosis of DR. The use of AI will allow to keep the quality of the eye care at least on the same level despite the raising number of the patients with diabetes.
Collapse
|
27
|
Qian F, Schumacher PJ. Latest Advancements in Artificial Intelligence-Enabled Technologies in Treating Type 1 Diabetes. J Diabetes Sci Technol 2021; 15:195-197. [PMID: 32840141 PMCID: PMC7782992 DOI: 10.1177/1932296820949940] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Affiliation(s)
- Feng Qian
- Department of Health Policy, Management, and Behavior, School of Public Health, University at Albany-State University of New York, Rensselaer, NY, USA
- Feng Qian, MD, PhD, MBA, One University Place, GEC Rm169, Rensselaer, NY 12144-3445, USA.
| | - Patrick J. Schumacher
- Department of Health Policy, Management, and Behavior, School of Public Health, University at Albany-State University of New York, Rensselaer, NY, USA
| |
Collapse
|